Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333:509-510 (9 September), doi:10.1136/bmj.38953.598947.80
May raise unrealistic expectations
| The first 150 words of the full text of this article appear below. |
The discovery earlier this year that a variant of the TCF7L2 (transcription factor 7-like 2) gene is associated with type 2 diabetes was reported in a front page story in the New York Times.1 2 The principal investigator, Kari Stefansson, told the newspaper that the discovery could lead to a diagnostic test to identify people who carry the variant gene. People who knew of their extra risk, he said, would be motivated to avoid the lifestyle habits that lead to diabetes. A Scottish scientist headed the research team, which led the Glasgow Herald to report, "Discovery of holy grail will help scientists treat diabetes."3
Undeniably this discovery is noteworthy. Type 2 diabetes is a leading cause of morbidity and mortality in the developed world and is increasing in prevalence worldwide. The association is robustthe finding has been replicated in three large independent study populations and offers potential new insight
A Cecile J W Janssens, epidemiologist
Department of Public Health, Erasmus MC University Medical Centre Rotterdam, 3000 CA Rotterdam, Netherlands
(a.janssens@erasmusmc.nl)
Marta Gwinn, epidemiologist, Rodolfo Valdez, epidemiologist, K M Venkat Narayan, chief, Muin J Khoury, director
Centers for Disease Control and Prevention, Atlanta, GA 30341, USA